Ubs Group Ag Cyclacel Pharmaceuticals, Inc. Transaction History
Ubs Group Ag
- $528 Billion
- Q1 2025
A detailed history of Ubs Group Ag transactions in Cyclacel Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 5,378 shares of CYCCP stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,378
Previous 84
6302.38%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding CYCCP
# of Institutions
5Shares Held
20.4KCall Options Held
0Put Options Held
0-
Ken Griffin Citadel Advisors LLC | Chicago, Il12.2KShares$00.0% of portfolio
-
Vsm Wealth Advisory, LLC Hunt Valley, MD2.78KShares$00.0% of portfolio
-
Sound Income Strategies, LLC94Shares$00.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$0100.0% of portfolio
About Cyclacel Pharmaceuticals, Inc.
- Ticker CYCCP
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,497,400
- Market Cap $16.5M